Inactive Instrument

ETFS S&P Biotech ETF

Equities

CURE

AU0000028110

ETFS S&P Biotech ETF Announces Financial Results for the Half Year Ended December 31, 2020

March 10, 2021 at 05:53 pm EST

ETFS S&P Biotech ETF announced financial results for the half year ended December 31, 2020. For the period, the company reported Total net investment income of AUD 3,259,000 against AID 624,000 a year ago. Profit for the half-year was AUD 3,197,000 against AID 604,000 a year ago.

Latest news about ETFS S&P Biotech ETF

ETFS S&P Biotech ETF Announces Updated Ordinary Dividend on CURE - ETFS S&P BIOTECH ETF for the Period of Twelve Months Ending June 30, 2021, Payable on July 15, 2021	21-07-01	CI
Etfs S&P Biotech Etf Announces Ordinary Dividend on Cure - Etfs S&P Biotech Etf for the Period of Twelve Months Ending June 30, 2021, Payable on July 15, 2021	21-06-24	CI
ETFS S&P Biotech ETF Announces Financial Results for the Half Year Ended December 31, 2020	21-03-10	CI
ETFS S&P Biotech ETF Announces Ordinary on CURE - Exchange Traded Fund Dividend for the Period Ending June 30, 2020, Payable on July 15, 2020	20-06-28	CI
ETFS S&P Biotech ETF Announces on CURE - Exchange Traded Fund Units Fully Paid for the Period of Twelve Months Ending June 30, 2020, Payable on July 15, 2020	20-06-24	CI
ETFS S&P Biotech ETF Announces Earnings Results for the Half Year Ended December 31, 2019	20-03-11	CI
ETFS S&P Biotech ETF Announces Ordinary Dividend, Payable on July 15, 2019	19-06-27	CI

Chart ETFS S&P Biotech ETF

Duration

Period

More charts

Company Profile

Sector

More about the company